1. Home
  2. Author
  3. Wileyto EP

Wileyto EP

References (2)

Title : Interaction between variation in the D2 dopamine receptor (DRD2) and the neuronal calcium sensor-1 (FREQ) genes in predicting response to nicotine replacement therapy for tobacco dependence - Dahl_2006_Pharmacogenomics.J_6_194
Author(s) : Dahl JP , Jepson C , Levenson R , Wileyto EP , Patterson F , Berrettini WH , Lerman C
Ref : Pharmacogenomics J , 6 :194 , 2006
Abstract : Dahl_2006_Pharmacogenomics.J_6_194
ESTHER : Dahl_2006_Pharmacogenomics.J_6_194
PubMedSearch : Dahl_2006_Pharmacogenomics.J_6_194
PubMedID: 16402081

Title : The functional mu opioid receptor (OPRM1) Asn40Asp variant predicts short-term response to nicotine replacement therapy in a clinical trial - Lerman_2004_Pharmacogenomics.J_4_184
Author(s) : Lerman C , Wileyto EP , Patterson F , Rukstalis M , Audrain-McGovern J , Restine S , Shields PG , Kaufmann V , Redden D , Benowitz N , Berrettini WH
Ref : Pharmacogenomics J , 4 :184 , 2004
Abstract : Lerman_2004_Pharmacogenomics.J_4_184
ESTHER : Lerman_2004_Pharmacogenomics.J_4_184
PubMedSearch : Lerman_2004_Pharmacogenomics.J_4_184
PubMedID: 15007373